DelMar Pharmaceuticals Announces First Quarter Fiscal Year 2018 Financial Results

DelMar Pharmaceuticals, Inc. (NASDAQ:DMPI) has announced financial results for Q1 ended September 30, 2017. The Company also announced a business update conference call and live webcast for investors, analysts and other interested parties on Tuesday, November 14, 2017 at 4:30 p.m. Eastern Standard Time.
Conference call details: for both “listen-only” participants and those who wish to take part in the question and answer portion of the call, the telephone Dial-in Number is 1 866 831 8713 (toll free) with Conference ID DELMAR.
As quoted in the press release:

At September 30, 2017, the Company had cash and clinical trial deposits on hand of approximately $14.1 million (unaudited).
For the quarter ended September 30, 2017, the Company reported a net loss of $2,666,406 or $(0.18) per share, compared to a net loss of $2,290,339, or $(0.23) per share, for the quarter ended September 30, 2016.

 
Click here to connect with DelMar Pharmaceuticals, Inc. (NASDAQ:DMPI) for an Investor Presentation

Source: www.prnewswire.com